Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit

Ksenya Shchors; Aristea Massaras; Douglas Hanahan

doi:10.1016/j.ccell.2015.08.012

Back

Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit

Article 2015 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2022

Added therapeutic benefit regarding ESMO-MCBS and the French health technology assessment of drugs granted early access program

Fiona Y.‐V. Pham, Emmanuelle Jacquet, Adrien Monard, Liora Brunel, Jean Yves Blay, Nicolas Albin

Article2012

Development and validation of a PCR‐based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs

Dimitra Stefanou, Hara Episkopou, Soterios Α. Kyrtopoulos, Aristotelis Bamias, Μαρία Γκοτζαμανίδου, Christina Bamia, Christina Liakou, Margarita Bekyrou, Petros P. Sfikakis, Meletios A Dimopoulos, Vassilis L. Souliotis

Article2025

Therapeutic Targeting of Hypoxia-Inducible Factors in Head and Neck Squamous Cell Carcinoma (HNSCC).

Elizabeth E. Wicks, Shaima Salman, Gregg L. Friedman

Article2008

A dual role of p53 in the control of autophagy

Ezgi Tasdemir, Maria Chiara Maiuri, Eugenia Morselli, Alfredo Criollo, Marcello D’Amelio, Mojgan Djavaheri‐Mergny, Francesco Cecconi, Nektarios Tavernarakis, Guido Guido Kroemer

Article2014

The therapeutic value of targeting inflammation in gastrointestinal cancers

Beicheng Sun, Michael Karin